Invivyd IVVD
NASDAQ IVVD
$0.87 +0.02 (+2.35%)
At close: Sep 30, 2026 · 4:00 PM EDT

Invivyd (IVVD) EBT Margin (2024 - 2026)

Updated

Invivyd (IVVD) reported EBT Margin of -320.76% for Q2 2026, down 192.98 percentage points from -127.78% a year earlier.

Analysis

Invivyd (IVVD) EBT Margin (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Invivyd's EBT Margin came in at -149.73%, up 95.94 percentage points year-over-year; for FY2025, it was -103.99%, up 592.81 percentage points from FY2024.

  • By year, EBT Margin came in at -696.80% in FY2024.
  • The Q2 2026 figure ranks as the lowest quarterly EBT Margin since Q3 2024.
  • Year over year, EBT Margin gained in three of the last four quarters, with an average year-over-year change of +626.67 percentage points.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 26.66%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 25.18%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -4.11%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 29.63%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 18.19%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 27.53%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -131.41%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 41.75%
10 Invivyd 256.44 Mn -250.20 Mn 13.01 Mn -320.76%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -320.76%
Dec 31, 2025 -72.96%
Sep 30, 2025 -83.96%
Jun 30, 2025 -127.78%
Mar 31, 2025 -149.70%
Dec 31, 2024 -139.14%
Sep 30, 2024 -670.01%
Jun 30, 2024 -2,175.22%
API Access

Invivyd EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=IVVD&period=max&api_key=YOUR_API_KEY